Oak Hill Capital

Oak Hill Capital is a New York private equity firm with a long operating history and an established middle-market healthcare practice focused on Care Delivery and Tech-Enabled Services. The firm’s positioning is that of a strategic value-creation investor, working with management teams in established operating businesses rather than chasing thematic technology bets. AI is not a stated focus.

Check sizes are $25M and above at the growth and buyout stage. Geographic focus is the United States. Specific portfolio companies and team members are not surfaced in the dataset available here; founders should consult Oak Hill’s website and recent press releases to identify which partners are most active in healthcare and what the recent transaction profile looks like.

For early-stage AI founders, Oak Hill is the wrong investor at the wrong stage. The fit is for established healthcare services platforms with EBITDA and a clear value-creation plan, where institutional capital and governance support can drive the next leg of growth. Founders considering a recapitalization, partial liquidity, or a buyout-funded expansion are the realistic profile. Expect a traditional PE process with rigorous financial diligence and an emphasis on operational improvement rather than technology novelty.